Select Medical (NYSE:SEM) Issues FY 2021 Earnings Guidance

Select Medical (NYSE:SEM) issued an update on its FY 2021 earnings guidance on Thursday morning. The company provided EPS guidance of $2.980-$3.090 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.030. The company issued revenue guidance of $6.05 billion-$6.15 billion, compared to the consensus revenue estimate of $5.99 billion.

Shares of Select Medical stock traded down $0.18 on Thursday, hitting $30.19. The company had a trading volume of 474,920 shares, compared to its average volume of 687,541. The company has a market cap of $4.05 billion, a PE ratio of 9.49, a PEG ratio of 0.75 and a beta of 1.23. Select Medical has a 52 week low of $23.91 and a 52 week high of $43.60. The company has a debt-to-equity ratio of 2.48, a current ratio of 1.34 and a quick ratio of 1.34. The business has a 50-day simple moving average of $33.89 and a 200-day simple moving average of $36.77.

Select Medical (NYSE:SEM) last issued its earnings results on Thursday, November 4th. The health services provider reported $0.57 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.05. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.44 billion. Select Medical had a net margin of 7.04% and a return on equity of 31.74%. The firm’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period last year, the firm posted $0.56 earnings per share. On average, equities research analysts predict that Select Medical will post 3.05 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 29th. Investors of record on Tuesday, November 16th will be issued a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a yield of 1.66%. The ex-dividend date is Monday, November 15th. Select Medical’s payout ratio is 15.72%.

Separately, Credit Suisse Group raised their price objective on shares of Select Medical from $37.00 to $39.00 and gave the stock a neutral rating in a research note on Tuesday, August 10th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Select Medical has an average rating of Buy and an average target price of $42.20.

A hedge fund recently raised its stake in Select Medical stock. LPL Financial LLC boosted its stake in Select Medical Holdings Co. (NYSE:SEM) by 6.8% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 10,572 shares of the health services provider’s stock after buying an additional 676 shares during the quarter. LPL Financial LLC’s holdings in Select Medical were worth $382,000 at the end of the most recent quarter. 76.30% of the stock is owned by institutional investors.

About Select Medical

Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared in a medically intensive environment, such as a skilled nursing facility.

Read More: What is Considered a Good Return on Equity (ROE)?

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.